CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
August 2014—SeraCare Life Sciences released four research panels that deliver hard-to-find material for hepatitis C, Chagas, and dengue.
The Worldwide Hepatitis C (HCV) AccuSet Performance Panel is a 20-member panel of undiluted, naturally occurring plasma samples. Panel members represent bleeds from multiple HCV-positive individuals from varying countries of origin. The panel of human plasma samples demonstrates a diverse collection of HCV genotypes 1, 2, 3, 4, 5, and 6 with varying subtypes. Test results from commercially available HCV genotype, RNA, and antibody assays are included for characterization of the panel members.
The Chagas (T. cruzi) AccuVert Seroconversion Panel is a 10-member panel of undiluted, naturally occurring plasma samples that represents serial bleeds collected over 118 days from a single individual during the development of a Chagas infection and subsequent response.
The Chagas (T. cruzi) Mixed Titer AccuSet Performance Panel is a 21-member panel of undiluted, naturally occurring plasma samples. Panel members represent bleeds from multiple individuals positive for Chagas disease from varying countries of origin.
The new Dengue Early Infection AccuSet Performance Panel is a six-member panel of undiluted, naturally occurring plasma samples that represents serial bleeds collected over 14 days from a single individual during the development of a dengue infection and subsequent response. Test results from commercially available dengue assays are included for characterization of the panel members. This panel of human plasma samples is positive for dengue RNA, NS1 antigen, and IgM and IgG antibodies.
SeraCare, 800-676-1881